TYRA · Tyra Biosciences, Inc.

$26.05 +0.36 (+1.40%) At close · Aug 21

Market Cap

$1.53B

59.68M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Todd Harris	Chief Executive Officer	$658,000	—	—	$4,568,037	$325,710	$15,250	$5,566,997
Bhavesh Ashar	Chief Operating Officer	$45,833	—	—	$4,638,420	—	$1,021	$4,685,274
Douglas Warner	Chief Medical Officer	$551,200	—	—	$1,607,560	$198,432	$15,051	$2,372,243

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Todd Harris	Chief Executive Officer	$632,700	—	—	$6,503,016	$433,400	$950	$7,570,066
Douglas Warner	Chief Medical Officer	$165,625	—	—	$4,469,114	$90,465	$313	$4,725,517
Daniel Bensen	Chief Operating Officer	$475,900	—	—	$1,917,556	$260,793	$950	$2,655,199

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Todd Harris	Chief Executive Officer	$608,400	—	—	$3,560,469	$456,300	$950	$4,626,119
Alan Fuhrman	Chief Financial Officer	$457,600	—	—	$2,767,712	$274,560	$30,933	$3,530,805
Hiroomi Tada	M.D., Ph.D. Chief Medical Officer	$509,600	—	—	$1,596,107	$305,760	$950	$2,412,417
Daniel Bensen	Chief Operating Officer	$457,600	—	—	$1,186,823	$274,560	$950	$1,919,933

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
General Counsel	—	$275,000	—	—	$2,132,978	$193,600	$23,130	$2,624,708
Daniel Bensen	Chief Operating Officer	$436,250	—	—	$1,798,839	$193,600	$950	$2,429,639
Todd Harris	Chief Executive Officer	$580,625	—	—	$1,384,209	$321,750	$950	$2,287,534
Hiroomi Tada	M.D., Ph.D. Chief Medical Officer	$486,250	—	—	$563,937	$215,600	$950	$1,266,737

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Todd Harris	Chief Executive Officer	$442,822	—	—	$5,764,839	$168,916	$986	$6,377,563
Ronald V. Swanson	Chief Scientific Officer	$432,316	—	—	$1,991,713	$102,951	$921	$2,527,901
Hiroomi Tada	M.D., Ph.D. Chief Medical Officer	$403,778	—	—	$1,991,713	$114,735	$1,135	$2,511,361
Daniel Bensen	Chief Operating Officer	$355,096	—	—	$1,991,713	$102,951	$1,020	$2,450,780

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Todd Harris	Chief Executive Officer	$350,200	—	$677,504	—	$210,120	$1,012	$1,238,836
Ronald V. Swanson	Chief Scientific Officer	$246,771	—	—	$128,306	$111,047	$900	$487,024

Executive changes

Person	Role	Change	Effective	Filed
Habib J. Dable	Class II director	Appointed	2026-04-16	2026-04-17
Julia Rueb	principal accounting officer	Appointed	2026-04-01	2026-04-02
Daniel Bensen	Chief Discovery Officer	Appointed	2025-12-01	2025-12-01
Bhavesh Ashar	Chief Operating Officer	Appointed	2025-12-01	2025-12-01
Adele M. Gulfo	director of the Board	Appointed	2025-01-29	2025-01-29
Nina Kjellson	Board and the Compensation Committee of the Board	Resigned	2025-01-29	2025-01-29
Siddarth Subramony, Ph.D.	Board of Directors	Resigned	2024-10-24	2024-10-25
S. Michael Rothenberg, M.D., Ph.D.	Director	Appointed	2024-05-07	2024-05-07
Susan Moran, M.D., M.S.C.E.	Director	Appointed	2024-05-07	2024-05-07
Isan Chen, M.D.	Director (and member of the Compensation Committee)	Resigned	2024-05-07	2024-05-07
Alan Fuhrman	Chief Financial Officer	Appointed	2023-01-01	2022-11-03
Esther van den Boom	Chief Financial Officer	Resigned	2022-12-31	2022-11-03

Key facts CIK 1863127 CUSIP 90240B106 13F (30d) 165 filings 163 filers Visit website Investor relations